1. Home
  2. OOMA vs ABEO Comparison

OOMA vs ABEO Comparison

Compare OOMA & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

N/A

Current Price

$13.95

Market Cap

332.9M

Sector

Technology

ML Signal

N/A

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$4.96

Market Cap

280.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OOMA
ABEO
Founded
2003
1974
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.9M
280.2M
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
OOMA
ABEO
Price
$13.95
$4.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$19.00
$18.75
AVG Volume (30 Days)
196.9K
978.0K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.74
EPS
0.09
1.35
Revenue
$114,490,000.00
$2,998,000.00
Revenue This Year
$20.64
N/A
Revenue Next Year
$3.72
$1,589.77
P/E Ratio
$156.67
$3.71
Revenue Growth
9.53
258.18
52 Week Low
$9.79
$3.93
52 Week High
$14.83
$7.54

Technical Indicators

Market Signals
Indicator
OOMA
ABEO
Relative Strength Index (RSI) 68.05 43.97
Support Level $10.95 $4.87
Resistance Level $14.83 $5.60
Average True Range (ATR) 0.46 0.20
MACD 0.18 -0.01
Stochastic Oscillator 75.57 22.97

Price Performance

Historical Comparison
OOMA
ABEO

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: